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Background: The active metabolite (1, 25-dihydroxycholecal-
ciferol) of vitamin D (25-hydroxycholecalciferol) leads to acti-
vation of macrophages and deficiency of vitamin D seems to 
be involved in the risk of tuberculosis. The effects of vitamin 
D are exerted by interaction with the vitamin D receptor 
(VDR) and may be influenced by polymorphism in the VDR 
gene. In this study , variation in the VDR gene was inves-
tigated in Korean population with tuberculosis. Methods: We 
typed three VDR polymorphisms of restriction endonuclease 
sites for TaqI, BsmI and FokI in 155 patients with tuber-
culosis and 105 healthy volunteers. Results: The frequencies 
of FokI genotypes determined from TB patients were 29.13% 
for  FF, 56.31% for Ff, and 14.56% for ff. We observed 
1.4-fold increased prevalence of the Ff genotype in TB pa-
tients compared with normal healthy groups (p＝0.0857). 
However, there was no significant association between the 
genotype groups, TB patient and normal control, for FokI 
polymorphism. There was also no significant association be-
tween VDR gene and tuberculosis in another polymorphism 
(BsmI and TaqI).  Conclusion: Three polymorphisms (TaqI, 
BsmI and FokI) in the VDR gene do not appear to be respon-
sible for host susceptibility to human tuberculosis in Korean 
population.
[Immune Network 2011;11(5):253-257]
INTRODUCTION
Most of the worldʼs peoples are exposed and infected to a 
variety  of  mycobacterial  species.  Even  if  rarely  pathogenic, 
mildly virulent mycobacteria such as Bacille Calmette-Guerin 
(BCG) and most mycobacteria may cause many different of 
clinical diseases. Mycobacterium tuberculosis and M. leprae, 
causing tuberculosis (TB) and leprosy, respectively, are more 
virulent. Remarkably, only a minority of individuals develops 
clinical  disease,  even  though  infected  with  virulent  myco-
bacteria. Susceptibility to disease after infection by mycobac-
teria  is  influenced  by  environmental  and/or  host  genetic 
factors. The interindividual variability of clinical outcome is 
thought to result, partially, from variability in the genes that 
control  host  defense  (1,2). 
    Host  genetic  factors  including  major  histocompatibility 
complex (MHC) polymorphisms influence both susceptibility 
to leprosy and TB (3-5). Non-MHC genes may also play an 
important role but remain undefined. Genetic variation stud-
ies of TB and leprosy have defined a role for HLA-DR (6,7) 
and variants of the NRAMP1 gene (8) in susceptibility to TB 
and  leprosy.
  V i t a m i n  D  h a s  a n  i m m u n o r e g u l a t o r y  r o l e  m e d i a t e d  b y  
binding to the vitamin D receptor (VDR) in monocyte, macro-
phages, and lymphocytes (9-11). Vitamin D status seems to 
be  involved  in  the  development  of  TB  (12-15).  VDR  poly-
morphisms are occurred in several restriction enzyme sites. 
F o k I  a n d  T a q I  r e s t r i c t i o n  s i t e s  a r e  t h e  b e s t  k n o w n  p o l y -
morphisms  of  VDR  gene  (13,16).  We,  herein,  investigated 
VDR genotype on susceptibility to TB and report an analysis 
of the polymorphisms in the FokI, BsmI, and TaqI restriction 
fragment length polymorphism (RFLP) of the VDR gene (Fig. VDR Polymorphism in Korean with Tuberculosis
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Figure 1. The human vitamin D recep-
ter (VDR) chromosomal genes, contai-
ning a total 11 exons, are variably pre-
sent in VDR transcripts. Three poly-
morphisms, including a FokI,  BsmI, 
and  TaqI site, are shown and discus-
sed in the text. The figure is adapted 
from the schematic view in reference 
4.
Table I. Information of subjects for this study
Subjects Total no.
type of subjects
Sex Average Average 
age medication Male Female
Tuberculosis 155 89 66 40 3.6 (month)
Normal healthy 105 67 38 24 -
1) in TB and normal control samples collected from Korean 
population.
MATERIALS AND METHODS
Subjects
T B  p a t i e n t s  w e r e  r e c r u i t e d  f r o m  S t .  P a u l  H o s p i t a l ,  S e o u l ,  
Korea from 2001 to 2002. M. tuberculosis infection was con-
firmed by AFB (Acid-Fast Bacilli) staining in their sputum and 
by culture. The control group comprised healthy, blood do-
nors  with  no  history  of  TB  or  other  immune  diseases.
  The TB patients comprised 89 males and 66 females, and 
their ages ranged from 17 to 69 years. All patients were diag-
nosed with pulmonary TB and their mean duration of therapy 
was about 6.6 years. Healthy normal control subjects with no 
history of previous tuberculosis consisted of 67 males and 38 
females,  with  age  ranging  from  21  to  52  years  (Table  I). 
Written  consent  was  obtained  from  each  participant.
Preparation of genomic DNA 
The genomic DNA from the study subjects was isolated from 
PBMC. We prepared PBMCs from heparinized blood, isolated 
by  centrifugation  through  Ficoll-Hypaque  density  gradient, 
then washed with DPBS (Sigma Chemical Co., St. Louis, MO. 
USA). 10
6 of PBMC were treated with PCR-K buffer [10× PCR 
buffer 1 ml, NP-40 40μl, Tween-20 45μl, protease K (20 mg 
ml
－1) 30μl, D.W. 8.8 ml] 1 ml, incubated at 58
oC for 1 hr 
and then incubated at 95
oC for 10 min to inactivate proteinase 
K .  T h i s  p r o d u c t  w a s  u s e d  a s  a  t e m p l a t e  D N A  f o r  P C R .
VDR polymorphisms
DNA was used in the PCR amplification of sequences contain-
ing  previously  described  VDR  restriction-fragment-length 
polymorphisms defined by the restriction endonucleases TaqI, 
FokI,  and  BsmI.  The  primer  sequences  used  in  this  study 
were as follows: 5'-cag agc atg gac agg gag caa g-3' and 5'-ggt 
ggc ggc agc gga tgt acg t-3' for TaqI; 5'-agc tgg ccc tgg cac 
tga ctc tgc tct-3' and 5'-atg gaa aca cct tgc ttc ttc tcc ctc-3' 
for FokI; 5'-aac ttg cat gag gag gag cat gtc-3' and 5'-gga gag 
g a g  c c t  c t g  t c c  c a t  t t g - 3 '  f o r  BsmI. 
    The  cycling  profile  involved  denaturation  at  94
oC  for  15 
sec, annealing at 65
oC (TaqI) and 55
oC (FokI and BsmI) for 
30 sec, and extension at 72
oC for 30 sec for 35 cycles. Final 
extension was continued at 72
oC for 10 min. The amplifica-
tion was carried out in a GeneAmp PCR system 9600 (Applied 
Biosystems,  Branchburg,  CT,  USA). 
  PCR products were digested overnight with restriction endo-VDR Polymorphism in Korean with Tuberculosis
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Table II. Vitamine D receptor (VDR) gene polymorphisms in 
patients with tuberculosis and healthy controls
Genotype TB patients (%) Healthy controls (%)
TaqI
TT 134 (89.93)   85 (90.43)
Tt   14 (9.40)     8 (8.51)
Tt     1 (0.67)     1 (1.06)
Total 149 (100)   94 (100)
Allele frequencies
T 282 (94.63) 178 (94.68)
t   16 (5.37)   10 (5.32)
BsmI
BB     2 (1.33)     0 (0)
Bb   13 (8.67)     8 (9.64)
bb 135 (90.0)   75 (90.36)
Total 150 (100)   83 (100)
Allele frequencies
B   17 (5.67)     8 (4.82)
b 283 (94.33) 158 (95.18)
Table III. Distribution of FokI genotypes in TB patients and normal
subjects
Genotype
Subjects
p value
Normal healthys (%) TB patients (%)
FF   41 (39.05)   30 (29.13)
Ff   43 (40.95)   58 (56.31) 0.0857
ff   21 (20.00)   15 (14.56)
Total 105 (100) 103 (100)
Allele frequencies
F 105 (55.26) 118 (57.28) 0.6858
f   85 (44.74)   88 (43.72)
Phenotype frequencies
F positive   84 (56.76)   88 (54.66) 0.7107
f positive   64 (43.24)   73 (45.34)
A B
Figure 2.  FokI restriction patterns of the various genotypes. PCR 
products before (A) and after (B) treatment of enzyme were showed. 
B. Three restriction fragments were present at 266, 193, and 73 bp.
The  FF genotype (B-1) had only the 266 bp band, the ff genotype
(B-3) had the two bands at 193 and 73 bp, and the Ff heterozygous
genotype (B-2) had the three bands.
nuclease so the reaction could proceed to completion, in ac-
cordance  with  the  manufacturerʼs  instructions  (Roche 
Molecular  Biochemicals,  Indianapolis,  IN,  USA).  Digested 
products were analyzed by electrophoresis in a 2% agarose 
gel  and  ethidium  bromide  staining.
Statistical analysis 
The  genotype  frequencies  of  each  of  the  SNPs  were  com-
pared  by  the  chi-square  tests,  Fisherʼs  exact  test  and 
Cochran-Armitage  Trend  Test.  Logistical  regression  analyses 
with  three  alternative  models  (additive,  dominant  and  re-
cessive) were used to calculate the odds ratios (OR) and 95% 
confidence  intervals  (CI)  of  each  SNP.  Data  analyses  were 
performed using the computer software SAS 9.1.3 (SAS Inc., 
Cary,  NC,  USA).  All  tests  were  two  tailed  and  p＜.05  was 
considered  statistically  significant.
RESULTS
The results of genotyping of VDR gene for TB patients and 
healthy control are summarized in Table 2 and 3. First, for 
the TaqI and BsmI polymorphism, the TB patient and normal 
control groups had similar distribution, and there was no sig-
nificant difference in allele frequency distribution between pa-
tients and controls. In Table II, genotype frequency analysis 
of TaqI site in TB patients showed that the largest group con-
sisted  of  TT  homozygotes  (89.93%  of  149  genotypes),  fol-
lowed by the Tt heterozygous group (9.4%), while tt homo-
zygotes were 0.67% (1 of 149 genotypes). In contrast, while 
bb homozygotes was the largest group (90.0% of 150 geno-
types)  in  BsmI  genotype,  Bb  heterozygote  and  bb  homo-
zygote  are  8.67%  and  1.33%,  respectively.
  PCR products restricted with FokI were showed in Fig. 2. 
Three bands after treatment with enzyme were showed as FF 
homozygotes (266 bp), Ff heterozygotes (193 bp), and ff ho-
mozygotes (73 bp) according to the restriction pattern (Fig. 
2). Table III showed the FokI genotypes determinants for TB 
patients and normal groups. The frequencies of the FokI gen-
otypes were 29.13% for  FF, 56.31% for Ff, and 14.56% for 
ff. We observed 1.4-fold increased prevalence of the Ff geno-
type in TB patients compared with normal healthy groups (p
＝0.0857). However, there was no significant association be-
tween the genotype groups, TB patient and normal control, 
for  FokI  polymorphism  (Table  III).VDR Polymorphism in Korean with Tuberculosis
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Table IV. The differences of genotype frequencies of FokI and TaqI VDR gene between patients from Korea and the other countries
FokI FF (%) Ff (%) ff (%) Total (%) Reference
Korean   30 (29.13)   58 (56.31) 15 (14.56) 103 (100) In this study
European   40 (49.66)   52 (46.55) 13 (8.79) 105 (100)        19
African   56 (46.34)   38 (43.45)   4 (8.21)   98 (100)        19
Gujarati Asians*   52 (57)   31 (34)   8 (9)   91 (100)        13
TaqI TT (%) Tt (%) tt (%) Total (%) Reference
Korean 134 (89.93)   14 (9.4)   1 (0.67) 149 (100) In this study
Cambodia 325 (90.8)   30 (8.4)   3 (0.8) 358 (100)        20
Gambia 204 (50) 177 (43) 27 (6.6) 408 (100)        17
Gujarati Asians*   39 (43)   46 (51)   6 (6)   91 (100)        13
*Gujarati Asians were Hindu, resident in London (living in Harrow, UK).
DISCUSSION
In human, mycobacterial pathogenicity varies from one myco-
bacterial species to another. M. tuberculosis and related spe-
cies of TB complex are the agents of human TB, the leading 
infectious  disease  world-wide. 
    There is much variability among individuals in the response 
to mycobacterial infections, but it is not known why certain 
people develop disease when challenged with mycobacteria 
and others remain healthy. However, the intrinsic virulence 
of each mycobacterial species is not the sole pathogenic fac-
tor as the outcome of mycobacterial infection depends on the 
genetic backgrounds of the infected individual. The molecular 
basis of the genetic vulnerability underlying most mycobacte-
r i a l  d i s e a s e s  i n  h u m a n  r e m a i n s  i s ,  i n  l a r g e ,  u n k n o w n .
  Recently genetic variation has been shown to be associated 
with  single  nucleotide  polymorphisms  (SNP)  in  the  vitamin 
D receptor (VDR) gene in many populations of leprosy and 
TB (13,17,18). Epidemiological  evidence suggests that there 
is a link between vitamin D deficiency and susceptibility to 
leprosy  and  TB.
    Vitamin D metabolism leads to activation of macrophages 
and restricts the intracellular growth of mycobacteria. This ef-
fect  of  vitamin  D  may  be  influenced  by  polymorphisms  at 
three sites (TaqI, BsmI and FokI) in the vitamin D receptor 
(VDR) gene (11). Recent studies also have implicated varia-
tion of the vitamin D receptor (VDR) gene in susceptibility 
to several diseases, including hepatitis and tuberculosis (17). 
    Therefore, we studied the association between VDR poly-
morphism and TB in Korean population with pulmonary TB 
and we found that there is no significant association in our 
analysis  between  TB  patient s  a n d  V D R  p o l y m o r p h i s m s .  
However, we found the differences of genotype frequencies 
of TaqI and FokI VDR between patients from Korean and the 
other  countries  including  European,  African,  and  Gujarati 
Asian previously reported (Table IV). For example, while the 
relative  genotype  frequencies  of  FokI  polymorphism  in 
Korean patients were FF 29.13, Ff 56.31, and ff 14.56%, the 
genotype frequencies in African were FF 46.34, Ff 43.45, and 
ff 8.21%. And the relative genotype frequencies of TaqI poly-
morphism  in  Korean  were  TT 8 9 . 9 3 ,  Tt  9.4,  and  tt 0 . 6 7 % , 
whereas  the  frequencies  determined  on  Gambia  (African) 
were TT 50.0, Tt 43.0, and tt 6.6%. However it is uncertain 
if there are racial differences involved in environmental or ge-
netic  factors. 
  Although several investigators reported and suggested that 
the  VDR  polymorphism  may  be  of  immunoregulatory  im-
portance for many disease processes, it is not clear that the 
polymorphism determine susceptibility to the development of 
clinical  disease  or  susceptibility  to  infection.
  F u r t h e r  s t u d i e s  w i l l  b e  r e q u i r e d  t o  i n v e s t i g a t e  h o w  V D R  
polymorphism may influence susceptibility to infectious dis-
ease  or  development  of  clinical  disease.
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